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Background: Obesity has become an epidemic in worldwide population. Leptin gene defect could be one of the
causes for obesity. Two mutant obese rats WNIN/Ob and WNIN/GROb, isolated at National Centre for Laboratory
Animal Sciences (NCLAS), Hyderabad, India, were found to be leptin resistant. The present study aims to understand
the regulatory mechanisms underlying the resistance by promoter DNA methylation of leptin gene in these mutant
obese rats.
Methods: Male obese mutant homozygous, carrier and heterozygous rats of WNIN/Ob and WNIN/GROb strain of 6
months old were studied to check the leptin gene expression (RT-PCR) and promoter DNA methylation
(MassARRAY Compact system, SEQUENOM) of leptin gene by invivo and insilico approach.
Results: Homozygous WNIN/Ob and WNIN/GROb showed significantly higher leptin gene expression
compared to carrier and lean counterparts. Leptin gene promoter DNA sequence region was analyzed ranging
from transcription start site (TSS) to-550 bp length and found four CpGs in this sequence among them only three
CpG loci (-309, -481, -502) were methylated in these WNIN mutant rat phenotypes.
Conclusion: The increased percentage of methylation in WNIN mutant lean and carrier phenotypes is positively
correlated with transcription levels. Thus genetic variation may have effect on methylation percentages and
subsequently on the regulation of leptin gene expression which may lead to obesity in these obese mutant rat
strains.
Keywords: Leptin expression, Promoter DNA methylation, Insilico analysis, Obesity, WNINIntroduction
Obesity has become an alarming epidemic to global
health with increased hypertension, coronary athe-
rosclerosis, myocardial hypertrophy, type II diabetes and
cardiovascular morbidity & mortality. Although obesity
is caused by both genetic and environmental factors the
molecular mechanism underlying obesity is not yet well
established. It is certainly a multifaceted disease with
complex interactions between genetic traits and environ-
mental factors, regulated by epigenetic mechanisms.* Correspondence: rkrajender@yahoo.com
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article, unless otherwise stated.Earlier many experiments have been conducted to
study obesity and the underlying mechanisms involved
in various animal models especially in Ob/Ob and db/db
mouse strains, Zucker and Koletsky rat strains. Two mu-
tant obese rat strains were isolated from WNIN stock,
designated as WNIN/Ob and WNIN/GROb in 1994, at
National Institute of Nutrition, Hyderabad, India [1].
These mutant rats are characterized by hyperphagia,
hyperinsulinemia, hypertriglyceridemia, higher body fat%
(47%) and are found to be leptin resistant as well [1].
Additionally WNIN/GROb rat show impaired glucose
tolerance (IGT) too. The inheritance of obesity in these
rats follows a co-dominant pattern as per Mendelian
laws and the phenotypic ratio of the offspring is 1:2:1
(1 lean+/+ : 2 carrier+/- : 1 Obese-/-). Both the homo-
zygous obese male and females are infertile while thetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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taining the stock.
Interest on the pathophysiology of obesity has been in-
tensified recently with the discovery of leptin [2]. Leptin,
a 167 amino acid protein and the product of the obese
gene Leptin (LEP), is a key hormone primarily secreted
by adipocytes [3]. Leptin levels increase exponentially
with increasing fat mass [4,5]. Leptin inhibits food intake
and regulates energy intake and expenditure by central
action on the hypothalamus. Activation of central leptin
receptors increases the activity of the sympathetic ner-
vous system [6,7] which stimulates energy expenditure
in adipose tissue [8,9]. Leptin levels significantly increase
in obese humans and this endogenous hyperleptinemia
does not reduce appetite or increase energy expenditure
suggesting that they are leptin resistant. Recent studies
demonstrate that leptin promoter methylation regulates
leptin expression [10]. Melzner et al reported that CpGs
in the proximal leptin promoter were highly methylated
in pre-adipocytes and gets highly demethylated as they
mature to terminally differentiated adipocytes. This
suggests that the methylation of CpGs inhibits leptin ex-
pression, while their demethylation activates the expres-
sion [11]. Although WNIN/Ob rats and WNIN/GROb
were found to be leptin resistant like other rodent
models the regulatory mechanisms underlying this re-
sistance is not yet known. Thus the present study aims
to understand the leptin resistance by determining the
promoter DNA methylation pattern of leptin gene which
presumably should explain the extent of leptin expres-
sion seen in these animals.Methods
Animal study
The experimental procedure was approved by the ethics
committee on animal experiments at the National Insti-
tute of Nutrition (NIN), Hyderabad, India and was per-
formed in accordance with the principles of laboratory
animal care. Male obese WNIN rats i.e.homozygous,
WNIN/Ob obese (-/-), heterozygous WNIN/Ob carrier
(+/-), homozygous WNIN/Ob lean (+/+) and WNIN/
GROb obese (-/-), WNIN/GROb carrier (+/-), WNIN/
GROb lean (+/+) of 6 months old (3 per strain) were
obtained from National Centre for Laboratory Animal
Sciences (NCLAS), NIN, Hyderabad, India. They were
housed individually in polypropylene cages with wire
mesh bottom cases maintained at 22 ± 2°C, under stand-
ard lighting conditions (12-h light/dark cycle).Animals
were fed ad libitum with stock rat chow and free access
to deionized water. The animals were sacrificed and
their retroperitoneal adipose tissue was collected and
snap frozen in liquid nitrogen and stored at -80°C until
analysis.Leptin mRNA expression in retroperitoneal adipose tissue
by semi-quantitative PCR
Total RNA was isolated from 100 mg of adipose tissue
(retroperitoneal) using Qiazol reagent. This was followed
by the synthesis of cDNA from 2 μg of total RNA using
Invitrogen kit (Invitrogen Life technologies, Carlsbad,
CA). Primers were designed with the aid of primer quest
software (Integrated DNA Technologies, Corolville,
IOWA). Semi-quantitative PCR was conducted to analyze
the expression of leptin (5′ACTTCATTCCCGGGCTTC3′;
5′GGTCTCGCAGGTTCTCCA3′), with the internal stan-
dard18SrRNA (5′CCAGAGCGAAAGCATTTGCCAAGA3′;5′
AATCAACGCAAGCTTATGACCCGC3′). The ampli-
fied products were resolved on 1.2% agarose gel electro-
phoresis and the image was quantified with the Bio-Rad gel
documentation system using Quantity One software
(Bio-Rad Laboratories, Herculus, CA). Results were
expressed as the ratio of the intensities of the band of
the gene of interest to that of the 18s rRNA.
DNA isolation
DNA was isolated from 100 mg of retroperitoneal adi-
pose according to the manufacturer’s instructions of
QIAGEN DNeasy tissue kit (Qiagen India Pvt. Ltd.,
India). The isolated gDNA was quantified using a ND-
1000 spectrophotometer (Nano Drop Technologies, Inc).
Sodium bisulfite modification
Bisulfite modified gDNA was prepared using the EZ
DNA Methylation-Gold kit (Zymo Research, catalog
#D5005) according to the manufacturer’s instructions.
The bisulfate reaction was performed on 0.5 μg gDNA
and the reaction volume was adjusted to 20 μl with ster-
ile water and 130 μl of CT conversion reagent was
added. The sample tubes were placed in a thermal cycler
(Bio-Rad) and the following steps were performed: 10
min at 98°C, 2 h 30 min at 64°C and stored at 4°C. The
converted samples were added into Zymo-Spin ICTM
Column containing 600 μl of the M-Binding Buffer and
mixed by inverting the column several times. After mix-
ing, the column was centrifuged at full speed for 30 sec
and discarded the flow-through. The column was then
washed by adding 200 μl of M-Desulphonation buffer
and incubated at room temperature (20-30°C) for 15-20
min. After incubation, the column was centrifuged at full
speed for 30 sec. The column was again washed by add-
ing 200 μl of M-Wash buffer and spun at full speed (this
step was repeated). The converted gDNA was eluted by
adding 20 μl of M-Elution buffer into the column and
spin. The bisulfite converted gDNA samples were stored
at -20°C until methylation analysis. Pyro Q-CpG Software
(Biotage) was used to check automatically the generation
of dispensation order (sequence) and it also performs
quality control of each sample for completion of bisulfite
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estimation levels of non-converted DNA.
Quantitative methylation analysis
Quantitative methylation analysis of the leptin gene pro-
moter was performed with the MassARRAY Compact sys-
tem (Sequenom, San Diego, CA, USA). The target regions
of the sodium bisulfate treated gDNA were amplified by
PCR with a set of primers: leptin_10 left primer 5′TTATG
GATTAGTAATGAAGATTTTAATAGA3′; leptin_10 right
primer 5′TCAATAAAATACCCACCCTTAAAAA3′. Each
forward primer contained a 10-nucleotide tag (5′-AGGAA
GAGAG-3′) to balance the PCR, and each reverse primer
contained a T7 promoter tag and sequence insert (5′-CAG
TAATACGACTCACTATAGGGAGAAGGCT-3′) for in vitro
transcription. The amplification protocol comprised an
initial incubation at 94°C for 4 min; 45 cycles of de-
naturation at 95°C for 20 s, annealing at 62°C for 30 s,
and extension at 72°C for 1 min; and a final incubation
at 72°C for 3 min. Unincorporated deoxynucleoside tri-
phosphates were dephosphorylated by the addition of 2
μl of Premix for in vitro transcription including 0.3 U
of shrimp alkaline phosphatase (Sequenom, San Diego,
CA, USA). The reaction mixture was incubated at 37°C
for 40 min, after which the phosphatase was inactivated
by incubation for 5 min at 85°C. A portion of the PCR
products (2 μl) was then subjected to in vitro trans-
cription, with RNase A cleavage being used for the T-
reverse reaction (Sequenom). Samples were spotted
onto a 384-pad Spectro-CHIP (Sequenom) with the use of
a MassARRAYnanodispenser (Sequenom) and spectra
were acquired with a MassARRAY compact matrix-
assisted laser desorption ionization time-of-flight (MALDI-
TOF) mass spectrometer (Sequenom). The resulting
methylation calls were analyzed with EpiTyper software
(Sequenom) to generate quantitative results for each
CpG site or an aggregate of multiple CpG sites.
Insilico analysis of leptin promoter
The leptin gene promoter DNA sequence of rat was ob-
tained from the UCSC genome browser (http://genome.
ucsc.edu/). In this study the promoter was defined as
the one which can extend from transcription starting
site (TSS) to -550bp upstream. The CpG island searcherTable 1 The leptin promoter DNA sequence in silico analysis -
S.No Promoter length (bp) No. of CpG Position of
1 TSS to -100 0 0
2 −101 to -200 0 0
3 −201 to -300 0 0
4 −301 to -400 1 −309
5 −401 to -500 2 −447, -481
6 −501 to -550 1 −502(http://cpgislands.usc.edu) was used to screen for CpG
islands (D.T and P.A.J). The methylator software
(http://bio.dfci.harvard.edu/Methylator) was used to
identify CpG and predict whether CpG in a promoter
DNA sequence are likely to be methylated or not.
Statistical analysis
All values were represented as mean ± S.E. Data was
analyzed by one-way analysis of variance (ANOVA)
followed by the multiple range test or least significant
difference method. Wherever heterogeneity of variance
was observed, differences between groups were tested using
non-parametric Mann-Whitney U test. The differences
were considered significant at p < 0.05.
Results
Insilico analysis of leptin gene promoter DNA sequence
The rat leptin gene promoter DNA sequence (TSS
to -550bp) showed 118 C counts (19.6%), 144 G counts
(24%) and 5 GC counts (0.8%) and the odds ratio was
17.6%. There were no CGIs predicted in this 550bp
length upstream DNA sequence while four CpGs were
identified (Table 1). Among the identified CpGs only
two CpGs were predicted to be methylated. The closest
methylated CpG locus was noticed at -309bp distance
from the TSS and the other methylated site was located
at -502bp away from TSS.
Leptin gene expression in adipose tissue
Reverse transcription-PCR experiments were carried out
in visceral adipose tissue to evaluate the leptin mRNA
expression. Homozygous Ob/Ob was found to have
maximum leptin mRNA expression followed by carrier
and lean in that order. The semi-quantitative analysis of
leptin mRNA expression was found to be significantly
(p < 0.05) decreased in WNIN/Ob lean and WNIN/Ob
carrier rats when compared to their WNIN/Ob obese
phenotypes (Figure 1). Similarly, a significant decreased
leptin mRNA expression was also depicted in WNIN/
GROb lean and carrier rats when compared with their
homozygous obese rats (Figure 2). Interestingly, the
leptin mRNA expression levels were higher in all the
three phenotypes of WNIN/GROb when compared with
their WNIN/Ob rats. The percentage of relative mRNAThe CpG locus and predicted methylated CpG sites







Figure 1 Leptin gene expression in adipose tissue of WNIN/Ob rats.
Figure 2 Leptin gene expression in adipose tissue of WNIN/GROb rats.
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with WNIN/Ob rats. The similar trend was noticed be-
tween WNIN/Ob carrier Vs WNIN/GROb carrier and
WNIN/Ob lean Vs WNIN/GROb phenotypes.
Leptin gene promoter DNA methylation
Leptin gene promoter DNA sequence region was analyzed
ranging from TSS to – 550 bp length. It was found that
among the four CpGs present in this sequence only three
CpG loci were methylated in these WNIN mutant rat phe-
notypes. The percentages of leptin promoter DNA methy-
lation at three different loci -309, -481 and -502 were
noted in WNIN/Ob and WNIN/GROb phenotypes. It was
observed that the methylation percentage was less in
WNIN/Ob obese rats (95%) compared to their carrier
(97%) and lean (98%) counterparts at the locus -309. Simi-
larly the methylation percentage was less in WNIN/Ob
obese rats (91%) compared to their carrier (93%) and lean
(96%) counterparts at the locus -481. However the methy-
lation percentage was more in WNIN/Ob obese rats
(63%) compared to their carrier (57%) and lean (61%)
phenotypes at the locus -502 (Figure 3).
Similarly in WNIN/GROb phenotypes, the percentage
of leptin promoter DNA methylation was lower in obese
phenotype (63%) at the locus -309 when compared to
their carrier (79%) and lean rats (88%). Although the
methylation percentage in obese rats (79%) was compar-
able with that of carrier phenotypes (78%), it was found
to be lower in obese compared to lean rats (84%) at the
locus -481. However the methylation percentage was
higher in obese phenotypes (56%) followed by lean (51%)
and carrier rats (41%) at the third locus -502 (Figure 4).Figure 3 Leptin gene promoter DNA methylation in WNN/Ob rats.It was also observed that the methylation percentages
were found to be relatively more in WNIN/GROb mu-
tant phenotypes compared to WNIN/Ob phenotypes at
the locus -309 and -482 while the trend was similar in
the percentage of methylation in both the mutant rat
strains at the locus -502 (Figure 5).
Discussion
The fundamental feature of the epigenetic markers is
their dynamic flux, which is the basic mechanism of en-
vironmental adaptability [12]. Methylation of CpG sites
have been widely observed in vertebrates and occasion-
ally reported in invertebrates [13]. Regulatory motifs on
promoters can be identified by virtue of their preferential
location relative to the TSS. The changes in methylation
status of the CpG islands overlapping gene promoter
enable epigenetic control of transcription. At the same
time, established methylation pattern has to be main-
tained with high fidelity since aberrant methylation
events (hypo- and hyper-methylation) lead to dysregu-
lation of the downstream gene [14]. Methylation of
DNA essentially leads to a repression of transcription
by interfering with the binding sequence of transcrip-
tion factors and through the binding of methyl-CpG
binding proteins [15].
A comprehensive insilico analysis of epigenetic properties
of the rat leptin gene promoter DNA sequence necessitates
experimental testing that affords direct measurement of the
methylation state of this promoter region. In the present
study, 550bp length leptin gene promoter DNA sequence
was analysed and identified four CpGs which were in close
proximity to the TSS and had the potentials to be
Figure 4 Leptin gene promoter DNA methylation in WNN/GROb rats.
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study which noted that methylation surrounding the TSS is
tightly linked to transcriptional silencing while methylation
of more downstream regions is unassociated with the mag-
nitude of gene expression [16,17]. Considering that the
comparative genomics approach is widely used to identify
functional sequence elements and regulatory networks [18]
this analysis was performed as a prelude to the experimen-
tal testing of the leptin gene promoter methylation in
WNIN mutant rat genomic samples which may help to de-
sign the experiments, to minimize possible experimental
bias, and thus improve validity of the experimental data.
Leptin, a multifunctional hormone, is predominantly
delivered by mature adipocytes. The present study dem-
onstrated that the leptin mRNA expression levels were
varying with their adipose levels in WNIN mutant rat
strains i.e. WNIN/Ob & WNIN/GROb and their carrier
and lean counterparts. The varying adipose tissue levels
indicate that the genes associated with adipogenesis
regulation may be different in these mutant WNIN ratFigure 5 Epigram of leptin gene promoter in WNIN/Ob and WNIN/GRphenotypes. These observations are in agreement with
few reports which showed strong correlation between
the levels of leptin mRNA expression and adipocyte size
supporting the importance of leptin in altering the fat
mass [19,20]. Another study on human subjects showed
that the developmental increase in leptin mRNA expres-
sion in adipose tissue during childhood, reaching max-
imal capacity in adulthood [21]. In addition a study also
depicted an evidence linking leptin to a direct regulation
of adipose tissue metabolism through inhibition of lipo-
genesis and stimulation of lipolysis [22]. Thus these re-
sults support that the differentialexpression of leptin
mRNA in these mutant phenotypes could be due to the
genetic differences among the strains studied although
these animals were fed with the same rat chow. Accord-
ing to our knowledge this is the first report on leptin
mRNA expression in genetically mutant rat models orig-
inated from WNIN that follow the Mendelian genetic
ratio’s (1:2:1). However the underlying mechanism for
the close correlation between leptin mRNA level andOb rats.
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obese mutant rats.
Many researchers have suggested that the expression
of genes controlling energy homeostasis could be regu-
lated by epigenetic mechanisms, which may play a role
in the development of obesity [23,24]. Considering this,
the regulation of leptin gene expression in these rat
models was studied by epigenetic approach i.e. by ana-
lysing promoter DNA methylation in silico and in vivo
and correlated with gene expression. It was noticed that
the leptin gene promoter DNA methylation percentages
were varying in mutant WNIN obese rat phenotypes.
The decreased percentage of methylation in leptin gene
promoter in WNIN obese than in lean and carriers are in
accordance with a recent study which reported genetic
polymorphisms associated with differential methylation in
the H19/IGF2 locus [25]. Another report indicates that
genetic variation may have a substantial impact on local
methylation patterns [26,27], but neither the extent to
which methylation is affected by genetic variation, nor the
mechanisms are yet clear. Our results also demonstrated
that methylated CpGs are in close proximity to the TSS in
the rat promoter studied. This work is in agreement with
Melzner et al who showed that the three specific CpG
sites within the minimal LEP promoter region played an
important role in regulating reporter gene expression in
human adipose cell line [11].
The present study clearly demonstrated that the body
weights, adipocyte mass [28] and leptin gene expression
are in line with leptin promoter DNA methylation per-
centages in WNIN obese mutant rats suggesting that the
genetic differences can have profound influence on
methylation patterns. The present in silico methylation
prediction was in agreement with in vivo methylation
status. The sole exception was at the locus -481 which
showed methylation in in vivo, while the in silico, ana-
lysis of methylation could not predict. In silico analysis
also showed the presence of CpG at the locus -309 and its
predicted methylation, which was identified proximal to
the TSS in the rat promoter DNA sequence. Interestingly,
our in vivo studies also demonstrated clearly that methyla-
tion was more at locus -309 which regulated leptin gene
expression in WNIN mutant obese rat phenotypes. These
observations are in line with several studies which showed
that methylation of CpG sites that are close to the TSS in
promoter DNA sequence will have more effect on regula-
tion of gene expression [29]. Melzner et al. also reported
that the CpGs in the proximal leptin promoter were
highly methylated in pre-adipocytes and during matu-
ration toward terminally differentiated adipocytes, this
promoter region was found to be highly demethylated.
Hence it was clear that the CpG sites which are close
to TSS methylated may have profound effect on gene
expression.Conclusion
The present study clearly demonstrated that the leptin
gene expression is in line with leptin promoter DNA
methylation patterns in WNIN obese mutant rats sug-
gesting that genetic variation seemed to have an effect
on methylation percentages and subsequently on the
regulation of gene expression. These results may have
implications for the functional interpretation of me-
chanisms underlying association of genetic variants with
the development of obesity.
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